These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1668249)

  • 21. Expression of CD 21, CD 22, and the mouse erythrocyte receptor on peripheral B lymphocytes in rheumatoid arthritis.
    Hildebrandt S; von der Heydt I; von Wichert P
    Ann Rheum Dis; 1988 Jul; 47(7):588-94. PubMed ID: 2969703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG subclass specific antibody response to periodontopathic organisms in HIV-positive patients.
    Yeung SC; Taylor BA; Sherson W; Lazarus R; Zhao ZZ; Bird PS; Hamlet SM; Bannon M; Daly C; Seymour GJ
    J Periodontol; 2002 Dec; 73(12):1444-50. PubMed ID: 12546094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of T- and B-lymphocyte activation in severely burned patients.
    Schlüter B; König W; Köller M; Erbs G; Müller FE
    J Trauma; 1991 Feb; 31(2):239-46. PubMed ID: 1825229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-receptors of B lymphocytes.
    O'Rourke L; Tooze R; Fearon DT
    Curr Opin Immunol; 1997 Jun; 9(3):324-9. PubMed ID: 9203413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model.
    Gemmell E; Bird PS; Carter CL; Drysdale KE; Seymour GJ
    Clin Exp Immunol; 2002 May; 128(2):238-44. PubMed ID: 11985513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a CD21 receptor-deficient, non-Ig-secreting peripheral B lymphocyte subset in HIV-seropositive drug abusers.
    Benedetto A; Di Caro A; Camporiondo MP; Gallone D; Zaniratti S; Tozzi V; Elia G
    Clin Immunol Immunopathol; 1992 Feb; 62(2):139-47. PubMed ID: 1370396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of expression of the antigen identified by FMC7 upon human B-lymphocyte activation: evidence for differences between activation in vivo and in vitro.
    Ferro LM; Zola H
    Immunology; 1990 Mar; 69(3):373-8. PubMed ID: 2138127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible different mechanisms of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: opposite expression of low-affinity receptors for IgE (CD23) on their peripheral B cells.
    Kumagai S; Ishida H; Iwai K; Tsubata T; Umehara H; Ozaki S; Suginoshita T; Araya S; Imura H
    Clin Exp Immunol; 1989 Dec; 78(3):348-53. PubMed ID: 2532990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model.
    Gemmell E; Bird PS; Ford PJ; Ashman RB; Gosling P; Hu Y; Seymour GJ
    Oral Microbiol Immunol; 2004 Aug; 19(4):247-51. PubMed ID: 15209995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression.
    Rudge EU; Cutler AJ; Pritchard NR; Smith KG
    J Exp Med; 2002 Apr; 195(8):1079-85. PubMed ID: 11956299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and function of CD22, a B-cell restricted molecule.
    Moyron-Quiroz JE; Partida-Sánchez S; Donís-Hernández R; Sandoval-Montes C; Santos-Argumedo L
    Scand J Immunol; 2002 Apr; 55(4):343-51. PubMed ID: 11967115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of B lymphocytes: integrating signals from CD19, CD22 and Fc gamma RIIb1.
    Doody GM; Dempsey PW; Fearon DT
    Curr Opin Immunol; 1996 Jun; 8(3):378-82. PubMed ID: 8793993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of IgE synthesis by CD23/CD21 interaction.
    Bonnefoy JY; Gauchat JF; Life P; Graber P; Aubry JP; Lecoanet-Henchoz S
    Int Arch Allergy Immunol; 1995; 107(1-3):40-2. PubMed ID: 7542093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
    Leprince C; Cohen-Kaminsky S; Berrih-Aknin S; Vernet-Der Garabedian B; Treton D; Galanaud P; Richard Y
    J Immunol; 1990 Oct; 145(7):2115-22. PubMed ID: 2144544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new method for detachment of Dynabeads from positively selected B lymphocytes.
    Rasmussen AM; Smeland EB; Erikstein BK; Caignault L; Funderud S
    J Immunol Methods; 1992 Feb; 146(2):195-202. PubMed ID: 1371532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF; Tuscano J; Sato S; Kehrl JH
    Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The low-affinity receptor for IgE (Fc epsilon RII or CD23) as a therapeutic target.
    Conrad DH; Kilmon MA; Studer EJ; Cho S
    Biochem Soc Trans; 1997 May; 25(2):393-7. PubMed ID: 9191124
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of receptor beta-chain variable region by T cells in human periodontal disease.
    Gemmell E; Grieco DA; Yamazaki K; Nakajima T; Seymour GJ
    Arch Oral Biol; 1997; 42(10-11):683-94. PubMed ID: 9447258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The establishment of human T cell lines reactive with specific periodontal bacteria.
    Ishii T; Mahanonda R; Seymour GJ
    Oral Microbiol Immunol; 1992 Aug; 7(4):225-9. PubMed ID: 1383912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors.
    Bujanowski-Weber J; Brings B; Knöller I; Pfeil T; König W
    Immunology; 1989 Apr; 66(4):505-11. PubMed ID: 2523859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.